Partnership marks the first introduction of Shield™ multi-cancer detection test in the region with availability across Hong Kong, Singapore and the Philippines Eligible Manulife customers in Hong Kong ...

Claude Code 2.0 as it has been labelled by some introduces new features aimed at improving coding workflows and handling complex tasks more effectively. One notable addition is the “By the Way” ...

Experience urban warfare like never before! Sit behind the wheel of legendary armored vehicles, roll up to the battlefield, and drive out enemy forces to prove you’re the best tank driver in the armor ...

Code reviews are a critical part of modern software development, yet they can often become bottlenecks, especially when dealing with large or complex pull requests (PRs). Anthropic has this week ...

HONG KONG, SINGAPORE, and MANILA, Philippines, March 16, 2026 /PRNewswire/ -- Manulife today announced an exclusive partnership with Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology ...

Partnership marks the first introduction of Shield™ multi-cancer detection test in the region with availability across Hong Kong, Singapore and the Philippines Eligible Manulife customers in Hong Kong ...

Guardant Health Inc. (NASDAQ:GH) is one of the most promising stocks under $100 to buy. On March 16, Guardant Health announced the launch of its Shield multi-cancer detection/MCD test in several Asian ...

Partnership marks the first introduction of Shield™ multi-cancer detection test in the region with availability across Hong Kong, Singapore and the Philippines Eligible Manulife customers in Hong Kong ...

First insurer in Asia to bring the innovative blood-based multi‑cancer screening solution to Hong Kong, Singapore, and the Philippines HONG KONG, SINGAPORE, and MANILA, Philippines, March 16, 2026 ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the launch of the Shield™ multi-cancer detection (MCD) laboratory developed test (LDT) in multiple markets in ...